Gm Advisory Group, Inc. Pfizer Inc Transaction History

Gm Advisory Group, Inc.

$1.65 Billion
Q3 2024

A detailed history of Gm Advisory Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Gm Advisory Group, Inc. holds 28,871 shares of PFE stock, worth $768,546. This represents 0.05% of its overall portfolio holdings.

Number of Shares

28,871

Previous 30,732 6.06%

Holding current value

$768,546

Previous $859,000 2.79%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $51,549 - $58,416	-1,861 Reduced 6.06%	28,871 $835,000
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $126,300 - $148,000	-5,000 Reduced 13.99%	30,732 $859,000
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $139,857 - $160,601	5,402 Added 17.81%	35,732 $991,000
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $297,829 - $386,848	11,398 Added 60.2%	30,330 $873,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $66,137 - $77,308	-2,061 Reduced 9.82%	18,932 $627,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $5,129 - $5,934	142 Added 0.68%	20,993 $770,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $26,824 - $34,921	681 Added 3.38%	20,851 $850,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $5,218 - $6,812	-125 Reduced 0.62%	20,170 $1.03 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $30,807 - $37,607	704 Added 3.59%	20,295 $888,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $54,579 - $64,714	1,173 Added 6.37%	19,591 $1.03 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $122,747 - $152,099	2,683 Added 17.05%	18,418 $953,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $20,660 - $30,625	500 Added 3.28%	15,735 $929,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $117 - $151	3 Added 0.02%	15,235 $655,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $323 - $366	9 Added 0.06%	15,232 $596,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $91,528 - $103,225	2,733 Added 21.88%	15,223 $552,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $79,123 - $100,611	2,364 Added 23.35%	12,490 $460,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $84,613 - $99,271	2,665 Added 35.72%	10,126 $372,000
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $1,897 - $2,302	-63 Reduced 0.84%	7,461 $244,000
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $203,373 - $290,576	7,524 New	7,524 $246,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $231,164 - $262,341	-7,022 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $48,799 - $63,279	1,502 Added 27.21%	7,022 $252,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $56,250 - $61,800	-1,500 Reduced 21.37%	5,520 $234,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $57,705 - $65,790	-1,500 Reduced 17.61%	7,020 $306,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $8,583 - $10,410	249 Added 3.01%	8,520 $375,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $85,484 - $91,134	-2,592 Reduced 23.86%	8,271 $300,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $51,534 - $59,787	-1,615 Reduced 12.94%	10,863 $386,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $386,818 - $426,123	12,478	12,478 $445,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gm Advisory Group, Inc. with notifications on news.

Account

Gm Advisory Group, Inc. Pfizer Inc Transaction History